<img alt="" height="1" width="1" />Lexicon Pharma Announced IBS Drug Had Positve Results In Clinical Trial (LXRX)Trading Markets (press release)Chief scientific officer Dr. Brian Zambrowicz said, "Treatment with LX1031 reduced symptoms of IBS in this clinical trial, and holds promise for patients ...<nobr>and more »</nobr> |